Thank you for the opportunity to provide comments on the draft Viral Hepatitis National Strategic Plan for the United States: A Roadmap for Elimination 2021-2025 (VH Plan)…
Comments on draft sexually transmitted infections national strategic plan 2021-2025
Thank you for the opportunity to provide comments on the draft Sexually Transmitted Infections National Strategic Plan 2021-2025 (STI Plan). The HIV+Hepatitis Policy Institute is a leading HIV…
Comments on NAIC draft pharmacy benefit manager model law
Please find the attached comments by the HIV+HEP Policy Institute on the draft NAIC Pharmacy Benefits Manager (PBM) Model Law. The HIV+HEP Policy Institute is a leading HIV and hepatitis policy…
Comments on Medicaid rebate rule
The HIV+Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious…
Cost-sharing for prescription drugs; Comments on 2021 notice of benefit and payment parameters proposed rule
The HIV + Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to submit comments on the proposed Notice of Benefit…